Amphastar Pharma: Jumps on FDA nod for generic version of hypoglycemia drug

Amphastar Pharmaceuticals,

29/12/2020 13:06

** Drugmaker's shares  AMPH.O  rise 15.6% to $22 premarket -
set for best day in four years 
    ** Co says the U.S. FDA has approved the generic version of
Glucagon for Injection Emergency Kit, 1 mg for the treatment of
severe hypoglycemia  urn:newsml:reuters.com:*:nGNX4PdsDp
    ** Hypoglycemia is a condition in which blood sugar falls to
dangerously low levels
    ** AMPH plans to launch their generic version within two
months
    ** Co says the drug was determined by the FDA to be
bioequivalent and therapeutically equivalent to Eli Lilly's
 LLY.N  Glucagon emergency kit for low blood sugar
    ** Up to Monday's close, stock down ~1% YTD 

 (Reporting b Shivani Kumaresan in Bengaluru)
 ((Shivani.Kumaresan@thomsonreuters.com ; +1 646 223 8780))